亚太实业(000691) - 2013 Q4 - 年度财报

Financial Performance - The company's operating revenue for 2013 was ¥22,494,467, a decrease of 53.61% compared to ¥48,489,286 in 2012[21]. - Net profit attributable to shareholders for 2013 was ¥2,626,252.61, an increase of 132.42% from ¥1,129,976.74 in 2012[21]. - Basic earnings per share for 2013 were ¥0.0081, up 131.43% from ¥0.0035 in 2012[21]. - The net profit attributable to the parent company was 2.63 million yuan, an increase of 132.42% year-on-year[26]. - The company reported a net profit of CNY 2,626,252.61 in 2013, with no cash dividends distributed to shareholders[62]. - The company reported a total profit for the current period of ¥2,239,338.13, a recovery from a loss of ¥36,299,958.53 in the previous period[171]. - The net profit for the current period is also ¥2,239,338.13, compared to a net loss of ¥36,299,958.53 last year[171]. - The total comprehensive income for the current period, including net profit and other comprehensive income, is 3,125,828,000[181]. Cash Flow and Liquidity - The net cash flow from operating activities improved significantly to ¥2,200,086.06, a 409.29% increase from -¥711,336.64 in 2012[21]. - The company's operating cash inflow was 26.64 million yuan, down 40.84% from the previous year, while cash outflow was 24.44 million yuan, a decrease of 46.57%[39]. - Cash and cash equivalents at the end of the period increased to ¥3,049,996.96 from ¥876,778.90, marking a significant improvement[175]. - The company reported cash inflows from operating activities totaling ¥26,637,941.89, down from ¥45,026,573.64 in the previous period, a decrease of approximately 40.7%[174]. - The cash outflows from operating activities were ¥24,437,855.83, compared to ¥45,737,910.28 in the previous period, also a decrease of about 46.5%[174]. Assets and Liabilities - Total assets at the end of 2013 were ¥285,518,292.44, reflecting a 15.31% increase from ¥247,614,829.53 at the end of 2012[21]. - The company's total liabilities increased to CNY 119,679,311.04, up from CNY 84,901,676.33, reflecting a growth of 41%[164]. - The total current liabilities reached CNY 99,679,311.04, an increase of 53.4% from CNY 64,901,676.33[164]. - The company's total assets amounted to CNY 285,518,292.44, compared to CNY 247,614,829.53 at the beginning of the year, indicating a growth of 15.3%[164]. - The company's equity attributable to shareholders was CNY 149,270,265.95, a slight increase from CNY 146,644,013.34[164]. Operational Highlights - The company plans not to distribute cash dividends or issue bonus shares for the year[5]. - The company has identified potential risks in its future development, which are detailed in the board report[13]. - The company has not made any changes to its accounting policies or restated previous years' financial data[21]. - The company did not incur any research and development expenses during the reporting period[36]. - The company has maintained consistent accounting policies and has not reported any significant accounting errors during the reporting period[56]. Governance and Management - The company has established a governance structure with the shareholders' meeting as the highest authority, the board of directors as the decision-making body, and the supervisory board for oversight, ensuring effective operation and internal control[134]. - The company has a stable management team with key personnel having extensive experience in various sectors, including finance and engineering[119]. - The independent directors have been in their roles since April 2013, contributing to corporate governance and oversight[120]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to RMB 4.882 million, with an additional RMB 1.186 million from shareholder units, totaling RMB 6.068 million[126]. - The company has a total of 49 employees, including 7 technical personnel, 22 production personnel, 11 sales personnel, 4 financial personnel, and 5 administrative personnel[131]. Strategic Initiatives and Future Outlook - The company plans to enhance the profitability of its subsidiaries and ensure stable cash flow[54]. - The company aims to transition towards the production and sales of pharmaceutical products, despite lacking experience in this sector[55]. - The company plans to continue expanding its market presence and exploring new product development opportunities[186]. - The company has not disclosed any market expansion or acquisition strategies in the current report[120]. - The company is actively pursuing legal action against Beijing Blue Scenic Home to protect its interests and mitigate negative impacts[92]. Legal and Compliance Issues - The company is involved in ongoing bankruptcy liquidation proceedings for its subsidiary Tianjin Luyuan, with no new developments reported[66]. - The company’s subsidiary Tianjin Luyuan is facing a lawsuit with a claim amount of CNY 13,422,689.10, which may impact its financial position[66]. - The company has faced legal challenges related to a loan guarantee for Tianjin Luyuan Ecological Energy Co., Ltd., impacting its subsidiary's operations[102]. - The company has been involved in litigation regarding the enforcement of a court order related to the equity of a subsidiary, which is currently under seal by the Tianjin Second Intermediate People's Court[103]. - The company has not faced any penalties or corrective actions during the reporting period[95].